Case Comprehensive Cancer Center

Running trials

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  NCT07284849· Phase 3· Incyte Corporation· Source

• Recruiting

  A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

  NCT06805825· Phase 1· Novelty Nobility, Inc.· Source

• Recruiting

  Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

  NCT06386887· Case Comprehensive Cancer Center· Source

• Recruiting

  The Cancer of the Pancreas Screening-5 CAPS5)Study

  NCT02000089· Phase 3· Johns Hopkins University· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer2 recruiting
• Melanoma2 recruiting
• Kidney cancer1 recruiting
• Lung cancer1 recruiting
• Neuroendocrine tumours1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Withdrawn

  Single-Port Versus Multi-Port Robotic Radical Prostatectomy

  NCT04696263· Case Comprehensive Cancer Center· Source

• Completed

  Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

  NCT01302834· Phase 3· Radiation Therapy Oncology Group· Source

• Completed

  Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer

  NCT00309985· Phase 3· ECOG-ACRIN Cancer Research Group· Source

• Completed

  High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

  NCT00003641· Phase 3· ECOG-ACRIN Cancer Research Group· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Glioblastoma26 works · 0 trials